Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis--a prospective randomized study.

Hofbauer J, Höbarth K, Szabo N, Marberger M.

Br J Urol. 1994 Apr;73(4):362-5.

PMID:
8199822
2.

Alkali citrate for preventing recurrence of calcium oxalate stones.

Hauser W, Frick J, Kunit G.

Eur Urol. 1990;17(3):248-51.

PMID:
2190842
3.

Comparison of biochemistry and diet in patients with enterocystoplasty who do and do not form stones.

Hamid R, Robertson WG, Woodhouse CR.

BJU Int. 2008 Jun;101(11):1427-32. doi: 10.1111/j.1464-410X.2008.07492.x. Epub 2008 Feb 18.

4.
5.

Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers.

Fuselier HA, Moore K, Lindberg J, Husserl FE, Cole FE, Kok DJ, Whitehead D, Galliano DJ, Erwin DT.

Urology. 1998 Dec;52(6):988-94.

PMID:
9836542
6.
7.
8.

Can citrate therapy prevent nephrolithiasis?

Abdulhadi MH, Hall PM, Streem SB.

Urology. 1993 Mar;41(3):221-4.

PMID:
8442301
9.

The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.

Siener R, Schade N, Nicolay C, von Unruh GE, Hesse A.

J Urol. 2005 May;173(5):1601-5.

PMID:
15821507
10.

Value of repeated analyses of 24-hour urine in recurrent calcium urolithiasis.

Höbarth K, Hofbauer J, Szabo N.

Urology. 1994 Jul;44(1):20-4; discussion 24-5.

PMID:
8042263
11.

Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.

Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL.

J Urol. 2009 Mar;181(3):1140-4. doi: 10.1016/j.juro.2008.11.020. Epub 2009 Jan 18.

PMID:
19152919
12.

Effects of citrate on the different phases of calcium oxalate crystallization.

Tiselius HG, Berg C, Fornander AM, Nilsson MA.

Scanning Microsc. 1993 Mar;7(1):381-9; discussion 389-90. Review.

PMID:
8316807
13.

Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.

Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A.

J Urol. 1996 Mar;155(3):839-43.

PMID:
8583588
14.

[A study of allopurinol in the prevention of recurrent calcium oxalate stones].

Sonoda T, Koide T, Oka T, Sakaguchi H, Itatani H, Ohkawa T, Ebisuno S, Morimoto S, Yoshida O, Okada Y, et al.

Hinyokika Kiyo. 1985 Nov;31(11):2071-9. Japanese.

15.

Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.

Penniston KL, Nakada SY.

Urology. 2009 Mar;73(3):484-9. doi: 10.1016/j.urology.2008.10.035. Epub 2009 Jan 1.

PMID:
19118878
16.

[Oxalate stone prophylaxis by alkalinizing therapy (author's transl)].

Butz M.

Urologe A. 1982 May;21(3):142-6. German.

PMID:
7048691
17.

Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.

Zerwekh JE, Odvina CV, Wuermser LA, Pak CY.

J Urol. 2007 Jun;177(6):2179-84.

PMID:
17509313
18.

Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation.

Penniston KL, Steele TH, Nakada SY.

Urology. 2007 Nov;70(5):856-60. Epub 2007 Oct 24.

PMID:
17919696
19.

Comparative study of the effects of pyruvate and CG-120 in preventing experimental oxalate urolithiasis in rats.

Ogawa Y, Yamaguchi K, Tanaka T, Morozumi M.

Hinyokika Kiyo. 1986 Sep;32(9):1341-7.

20.

[Granulated potassium citrate in the prevention of calcium oxalate lithiasis].

Campoy Martínez P, Arrabal Martín M, Quintero Rodríguez R, Espinosa Olmedo FJ, Castillo Gómez J, García Pérez M.

Actas Urol Esp. 1994 Feb;18(2):101-5. Spanish.

PMID:
7976691

Supplemental Content

Support Center